EX-99.1 2 dva4487951-ex991.htm PRESS RELEASE DATED MAY 20, 2025. Exhibit 99.1 DaVita Inc. Announces Offering of $750 Million Senior Notes DENVER, May 20, 2025 (BUSINESS WIRE) -- DaVita Inc. (NYSE: DVA) (“DaVita”) announced today that it has commenced a private offering (the “offering”) of $750 million aggregate principal amount of its senior notes due 2033 (the “2033 notes”), subject to market and other conditions. DaVita intends to use the net proceeds from the offering (i) to repay outstanding revolving credit facility borrowings, together with related accrued and unpaid interest thereon, (ii) to pay any costs, fees and expenses in connection with the foregoing, and (iii) if any proceeds remain, for general corporate purposes, including, without limitation, for repurchases of capital stock, working capital and capital expenditures. The 2033 notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons in transactions outside the United States in compliance with Regulation S under the Securities Act. The offer and sal…
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
DaVita Inc.
DVANYSEEQUITYCurrent
Other Events
Item 8.01. Other Events. On May 20, 2025, DaVita Inc. (the “Company”) issued a press release, made pursuant to Rule 135c promulgated under the Securities Act of 1933, as amended, announcing the commencement of a private offering (the “Notes Offering”), subject to market and other conditions, of $750 million aggregate principal amount of its Senior Notes due 2033 (the “2033 Notes”).…
Company context
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey - from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home.